Pushing the Boundaries of Molecular Diagnostics

Boston will host the AMP 2025 Annual Meeting & Expo from 11–15 November and we look forward to joining the dynamic community of experts, innovators, and leaders. With globally renowned speakers, the meeting will deliver transformative insights into groundbreaking research and innovative technologies in this field. 

Innovation is fueling the shift from bench to bedside

Molecular diagnostics is advancing at lightning speed, powered by breakthroughs in cell-free testing, sequencing, automation, and AI. These innovations are not only expanding the boundaries of precision medicine but also transforming how discoveries transition from bench to bedside.

Latest technologies and trends

AMP 2025 focuses on the trends shaping molecular diagnostics. Cell-free DNA (cfDNA) testing is making minimally invasive testing a reality, providing clinicians with a powerful tool to detect genetic mutations, track tumor dynamics, and assess treatment responses. This meeting highlights the latest advancements in cfDNA testing, exploring both blood-based and non-blood-based samples and their applications in precision oncology.

Able to analyze substantial amounts of data rapidly and accurately, artificial intelligence (AI) and machine learning have the potential to revolutionize diagnosis, treatment, and patient care. The meeting showcases the latest AI applications such as digitally mining large biological datasets to accelerate antibiotic discovery, and how multi-modal foundation AI can help to improve clinical decision-making.

Automation is no longer optional for molecular diagnostics, it's essential. AMP 2025 provides a practical and real-world perspective on migrating a manual molecular assay to automation and the real-life challenges and solutions when implementing custom automation.

We are pioneers in automation of diagnostics workflows

Smart automation is revolutionizing life science and diagnostics. Decreasing the number of manual touchpoints streamlines workflows, increases throughput, enhances efficiency, and improves testing accuracy.

Our unique approach of combining device technology with biological processes enables us to analyze your biological workflows in terms of chemistry, consumables, equipment, and software. We have expertise in a variety of technologies including NGS, PCR, capillary electrophoresis, liquid handling, and sample preparation.

Why should you partner with us?

We have over 30 years of expertise in molecular diagnostics, protein analysis, and cell analysis. Our modular approach based on use of optimized modular units reduces the time and effort required for development, registration, and life-cycle management (LCM) and decrease COGS (Cost of Goods Sold).

Let’s meet and collaborate

Our experts, Alexis Tzannis and Martin Galic, will be on hand at AMP 2025 to answer any questions you may have about our products and technologies.

Whether you are interested in learning more about our diagnostic platforms or automation solutions, they are ready to help you find the right solutions for your needs.

Schedule a meeting with us!